Determinazione delle barriere rotazionali di nuovi atropisomeri N-N: confronto tra metodi DFT e sperimentali.

Theoretical DFT calculations on rotational barriers of tetrasubstituted hydrazines were performed in order to synthesize new enantioenriched atropoisomers with chiral N-N axis. The molecules studied were chosen to be subsequently synthesized through asymmetric organocatalysis. New atropoisomers with chiral N-N axis were synthesized through organocatalysis methods via enamine or phase transfer. Cinchona alkaloid derivatives were used as catalysts. HPLC analyzes show that the three new synthesized molecules are atropoisomers at room temperature. Using an asymmetric procedure to synthesize the molecules studied, it was possible to generate enantiomeric excesses that remained unchanged for more than three weeks. The experimental rotational barrier of one of the three synthesized compounds was calculated. The experimental energy barrier at 25°C (ΔG^≠=25,7 kcal/mol) was lower than the DFT calculations and with a tendency to increase with temperature, due to a negative reaction entropy.

TIDES unveiled: pioneering green peptides synthesis and oligonucleotides innovations in science

My PhD research focused on the development of environmentally sustainable methods for peptide synthesis. The traditional and toxic solvents and bases used in solid-phase peptide synthesis (SPPS) were replaced with eco-friendly alternatives to reduce the environmental impact. In particular, N-octylpyrrolidone was found to be an effective green solvent in combination with dimethyl carbonate, resulting in a 63-66% reduction in process mass intensity (PMI). In addition, a green base, DEAPA, was identified for Fmoc removal, which showed comparable results to piperidine, while being less regulated and toxic, and able to better control aspartimide-related side reactions. The study extended beyond SPPS to explore liquid-phase peptide synthesis (LPPS) and solution-phase peptide synthesis (SolPPS) using propylphosphonic anhydride (T3P®) as a coupling reagent. The developed green SolPPS using Cbz amino acids achieved exceptional efficiency, minimal racemisation and a PMI of 30 to introduce a single amino acid in the iterative process. This PMI value is the lowest ever reported for an oligopeptide synthesis protocol. This technique was extended to N-Boc amino acids in DCM, requiring aqueous workups and achieving 95% purity of Leu-Enkephalin. Finally, T3P® was found to be suitable for LPPS. An anchor, mimicking a resin, was used to allow precipitation or solubilisation of the growing anchored-peptide, depending on the polarity of the solvent used. Anisole and DCM resulted in a pentapeptide purity of over 95%. While at Oxford University, I synthesized a cleavable fragment that is sensitive to cathepsin B (CatB) and incorporated it into a cyclic antisense oligonucleotide (ASO) targeting the metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). ASO demonstrated good stability in a simulated in vivo environment using human serum and high affinity with complementary RNA. The Cyclic-ASO was opened by CatB in optimal conditions. Experiments highlight therapeutic potential and a novel method for controlling cyclic oligonucleotide activity, potentially enhancing cellular uptake.